India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The Union Ministry of Jal Shakti is taking big steps under Jal Jeevan Mission (JJM)…
The Ministry of Housing & Urban Affairs (MoHUA) hosted the AMRUT Mitra Mahotsav 2026 at…
The Union Minister of Food Processing Industries, Chirag Paswan, inaugurated a modern Common Incubation Centre…
Yoga has become one of the most recognised wellness practices across the world. It promotes…
Global credit rating agency Fitch Ratings has increased India’s GDP growth forecast for the financial…
A special celebration called Purple Fest was organised at Rashtrapati Bhavan on March 13, 2026…